Julio Bobes, PhD

  • 8Articles
  • 27.7KReads
  • 1998–2022Active
  • 48Collaborators
  • 296Citations

About

Julio Bobes, PhD, is affiliated with the Department of Psychiatry at Universidad de Oviedo and several research institutes in Oviedo, Spain, including CIBERSAM, ISPA, INEUROPA, and SESPA. His publications from 1998 to 2022 focus on schizophrenia and schizoaffective disorders, anxiety, COVID-19-related suicidal ideation, and suicide. His work addresses topics such as negative symptoms in psychosis, social anxiety disorder, and the impact of the COVID-19 pandemic on mental health. He has collaborated frequently with authors including Pilar A. Saiz and Celso Arango.

Publications

JCP
Suicidal Ideation and Associated Factors in Spain During the First Year of COVID-19
Brief Report

Suicidal Ideation and Associated Factors in Spain During the First Year of COVID-19

March 7, 2022

This study reports the prevalence of active and passive suicidal ideation in the general population of Spain at 3 timepoints during the COVID-19 pandemic.
, , , et al
JCP
Brief Report

Passive Suicidal Ideation in the Early Stage of the COVID-19 Pandemic and Lockdown in a Spanish Sample

October 6, 2020

This study draws on an online survey conducted to determine the prevalence of passive suicidal ideation early in the COVID-19 pandemic in Spain. Read the report to learn about...
, , , et al
JCP
Article

Persistent Negative Symptoms in First-Episode Psychosis

September 12, 2017

Although negative symptoms of psychosis may be less prominent than positive symptoms, they can still have an equally great impact on patient functioning. This study of patients with a...
, , , et al
JCP
Original Research

Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study

November 3, 2009

, , , et al
JCP
Original Research

Neurologic Soft Signs in Borderline Personality Disorder

April 15, 2006

, , , et al
JCP
Letter to the Editor

High Degree of Tolerability for Monotherapy With High Doses of Quetiapine: A Case Report

November 1, 2002

, , , et al
JCP
Article

Consensus Statement on Social Anxiety Disorder From the International Consensus Group on Depression and Anxiety

May 21, 1998

, , , et al
JCP
Article

How Is Recovery From Social Anxiety Disorder Defined?

May 21, 1998

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe